Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Luye Pharmaceutical is a key subsidiary of the Luye Pharma Group, specializing in the research, development, and manufacturing of innovative pharmaceutical products with a strong focus on traditional Chinese medicine modernization and chemical drugs. The company is best known for its flagship product, Xuezhikang, a naturally derived lipid-regulating agent used extensively for the treatment of hyperlipidemia and cardiovascular diseases. Operating out of Chengdu, Sichuan, the facility serves as a major production base for the group, adhering to high GMP standards to supply both domestic and international markets. Its business model integrates R&D with large-scale manufacturing, particularly in the therapeutic areas of cardiology and metabolism.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Luye Pharmaceutical.